ARWR 241115 35.00C (ARWR241115C35000) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

ARWR241115C35000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 6 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Health Check: How Prudently Does Arrowhead Pharmaceuticals (NASDAQ:ARWR) Use Debt?
Simply Wall StOct 25 15:40 ET
Express News | Arrowhead Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersOct 14 16:30 ET
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BusinesswireOct 14 16:30 ET
H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $60
Moomoo NewsOct 11 10:31 ET · Ratings
Buy Rating Justified by Arrowhead Pharmaceuticals' Advancements in CNS-Targeted RNAi Therapeutics
TipRanksOct 11 09:55 ET · Ratings
Arrowhead Pharmaceuticals Inc (ARWR) Q3 2024 Earnings Call Highlights: Navigating Financial ...
Yahoo FinanceOct 9 17:53 ET

Comments

stockhub

Apr 7 11:23

Hope price action is consistent with result

Plozasiran reduced triglycerides and APOC3 up to a mean maximum of 86% and 90% respectively in patients with severe hypertriglyceridemia
$Arrowhead Pharmaceuticals (ARWR.US)$

Mooers' Insights

Tonyco

Apr 6 22:01

$Arrowhead Pharmaceuticals (ARWR.US)$
Insiderd selling shares and financials dont look good. Im guessing they dont have anything in the pipeline?

Moomoo AI

Mar 8 05:54

The company's poor performance and the CEO's high pay, despite falling earnings and shareholder value, may upset shareholders. The upcoming AGM on March 14th is a chance for shareholders to hold the board and management accountable.

We Think Shareholders May Want To Consider A Review Of Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) CEO Compensation Package

zulia3003

Mar 7 11:34

$Arrowhead Pharmaceuticals (ARWR.US)$ why drop today?

AuthPresidentColor8c

Mar 1 10:33

$Arrowhead Pharmaceuticals (ARWR.US)$ such a odd spot here